Abstract:This study aimed to investigate the potential of beef peptides (BP) in mitigating muscle atrophy induced by dexamethasone (DEX) and to elucidate the underlying three mechanisms in vitro focusing on protein degradation, protein synthesis, and the oxidative stress pathway. Finally, the anti-atrophic effect of BP was treated to enhance through purification and isolation. BP was generated using beef loin hydrolyzed with Alcalase/ProteAX/Trypsin, each at a concentration of 0.67%, followed by ultrafiltration through a 3kDa. BP (10-100 μg/mL) dose-dependently counteracted the DEX-induced reductions in myotube diameters, differentiation fusion, and maturation indices (p < 0.05). Additionally, BP significantly reduced FoxO1 protein dephosphorylation, thereby suppressing muscle-specific E3 ubiquitin ligases such as muscle RING-finger containing protein-1 and muscle atrophy F-box protein in C2C12 myotubes at concentrations exceeding 25 μg/mL (p < 0.05). BP also enhanced the phosphorylation of protein synthesis markers, including mTOR, 4E-BP1, and p70S6K1, in a dose-dependent manner (p < 0.05) and increased the mRNA expression of antioxidant enzymes. Fractionated peptides derived from BP, through size exclusion and polarity-based fractionation, also demonstrated enhanced anti-atrophic effects compared to BP. These peptides downregulated the mRNA expression of primary muscle atrophy markers while upregulated that of antioxidant enzymes. Specifically, peptides GAGAAGAPAGGA (MW 924.5) and AFRSSTKK (MW 826.4) were identified from fractionated peptides of BP. These findings suggest that BP, specifically the peptide fractions GAGAAGAPAGGA and AFRSSTKK, could be a potential strategy to mitigate glucocorticoid-induced skeletal muscle atrophy by reducing E3 ubiquitin ligases activity.

Beef peptides mitigate skeletal muscle atrophy in C2C12 myotubes through protein degradation, protein synthesis, and oxidative stress pathway